Astera Labs (NASDAQ:ALAB) Trading Down 6.2% - Here's Why

Key Points

• Astera Labs shares fell 6.2% to about $278.57 in Tuesday trading, with volume down 87% from the average session. The stock remains highly valued, with a market capitalization of $48.22 billion, a P/E ratio of 137.68 and a beta of 3.84.
• The company recently exceeded quarterly expectations, reporting $0.80 in earnings per share versus the $0.69 consensus estimate and $392.4 million in revenue versus $360.85 million expected. Revenue grew 104.5% year over year, while analysts maintain a “Moderate Buy” consensus rating and an average price target of $340.53.
• Insiders sold substantial holdings over the past quarter, totaling 419,244 shares worth approximately $163.1 million. The reported sales included transactions by CEO Jitendra Mohan and director Jack R. Lazar, though the CEO’s sale was made to cover tax obligations tied to vested equity awards.

Astera Labs, Inc. (NASDAQ:ALAB - Get Free Report)'s stock price dropped 6.2% during trading on Tuesday . The stock traded as low as $278.00 and last traded at $278.5710. Approximately 687,281 shares changed hands during mid-day trading, a decline of 87% from the average session volume of 5,318,744 shares. The stock had previously closed at $296.98.

Wall Street Analysts Forecast Growth

ALAB has been the subject of several analyst reports. Citigroup restated a "buy" rating on shares of Astera Labs in a report on Wednesday, July 29th. Bank of America upped their price objective on Astera Labs from $240.00 to $450.00 and gave the company a "neutral" rating in a report on Tuesday, June 23rd. JPMorgan Chase & Co. increased their target price on shares of Astera Labs from $205.00 to $280.00 and gave the stock an "overweight" rating in a research report on Wednesday, May 6th. Weiss Ratings reissued a "hold (c)" rating on shares of Astera Labs in a research note on Tuesday, August 18th. Finally, Barclays increased their price objective on shares of Astera Labs from $200.00 to $325.00 and gave the stock an "equal weight" rating in a research note on Monday, July 20th. One investment analyst has rated the stock with a Strong Buy rating, thirteen have given a Buy rating and eight have given a Hold rating to the company's stock. Based on data from MarketBeat.com, the company currently has an average rating of "Moderate Buy" and an average price target of $340.53.

Astera Labs Stock Down 6.4%

The business has a fifty day moving average of $339.53 and a 200 day moving average of $250.89. The firm has a market cap of $48.22 billion, a P/E ratio of 137.68 and a beta of 3.84.

Astera Labs (NASDAQ:ALAB - Get Free Report) last released its quarterly earnings results on Tuesday, August 4th. The company reported $0.80 earnings per share for the quarter, topping the consensus estimate of $0.69 by $0.11. The business had revenue of $392.40 million for the quarter, compared to the consensus estimate of $360.85 million. Astera Labs had a net margin of 30.74% and a return on equity of 19.24%. The company's quarterly revenue was up 104.5% on a year-over-year basis. During the same period last year, the firm earned $0.44 earnings per share. Astera Labs has set its Q3 2026 guidance at 1.160-1.210 EPS. On average, sell-side analysts expect that Astera Labs, Inc. will post 2.7 EPS for the current fiscal year.

Insider Activity at Astera Labs

In other news, Director Jack R. Lazar sold 10,000 shares of the stock in a transaction dated Thursday, June 4th. The stock was sold at an average price of $355.17, for a total transaction of $3,551,700.00. Following the transaction, the director owned 75,688 shares of the company's stock, valued at approximately $26,882,106.96. This represents a 11.67% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is accessible through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, CEO Jitendra Mohan sold 90,630 shares of the company's stock in a transaction dated Monday, August 17th. The stock was sold at an average price of $340.35, for a total transaction of $30,845,920.50. Following the sale, the chief executive officer directly owned 1,266,665 shares in the company, valued at $431,109,432.75. This represents a 6.68% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Insiders have sold a total of 419,244 shares of company stock worth $163,135,169 over the last quarter. 10.40% of the stock is currently owned by corporate insiders.

Institutional Inflows and Outflows

A number of institutional investors and hedge funds have recently modified their holdings of ALAB. Keating Financial Advisory Services Inc. purchased a new stake in Astera Labs during the second quarter valued at approximately $25,000. Archer Investment Corp acquired a new position in shares of Astera Labs during the second quarter worth about $30,000. Transamerica Financial Advisors LLC acquired a new stake in Astera Labs in the 2nd quarter worth about $35,000. Continuum Advisory LLC purchased a new position in Astera Labs in the second quarter valued at about $37,000. Finally, Johnson Financial Group Inc. acquired a new position in Astera Labs during the 2nd quarter worth $43,000. 60.47% of the stock is owned by institutional investors.

Astera Labs Company Profile

Astera Labs is a fabless semiconductor company that develops connectivity solutions for data center and cloud infrastructure. The firm focuses on addressing signal integrity and link management challenges that arise as server architectures incorporate higher-bandwidth processors and accelerators. Its technology is aimed at improving reliability and performance for high-speed interconnects used in servers, storage systems and compute accelerators.

The company's product portfolio centers on silicon devices and accompanying firmware and software that enhance and manage high-speed links.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source